Pricing

Log inSign up

Ashvattha Therapeutics

22 people · 0 jobs
‌

Ashvattha Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel hydroxyl dendrimer (HD) therapeutics (HDTs) to treat unmet medical needs in oncology, ophthalmology, and inflammatory diseases.

Industries

Biotechnology

Headquarters

Redwood City, United States

Employees

11-50

Links

Org chart

Jeffrey L. Cleland
Chairman, President & CEO
Collapse
SM
S. Sakura Minami
VP Translational Medicine And Nonclinical Development

Board & advisors

Kannan Rangaramanujam
Co-Founder & Chair, Scientific Advisory Board
BS
Barbara Slusher
Director
GM
George Montgomery
Director
Jay Zaveri
Director
YZ
Yuhang Zhao
Director
NP
Nicholas A. Peppas
Scientific Advisor
HG
Hamid Ghandehari
Scientific Advisor
KG
Kim Green
Scientific Advisor
SM
Samir Mitragotri
Scientific Advisor
GS
G. Mani Subramanian
Scientific Advisor

Similar companies

Tango Therapeutics

3 followers

Cellares

5 followers

Gilead Sciences

171 followers

Regeneron

144 followers

Illumina

81 followers

Agilent Technologies

89 followers

Verily Life Sciences

48 followers

Alexion Pharmaceuticals

49 followers

GRAIL

30 followers

Cytiva

19 followers

PerkinElmer

12 followers

Explore companies